Benzoates

Adjunctive use of daily sodium benzoate did not appear effective as early psychosis treatment, according to results of a randomized clinical trial published in JAMA Network Open.

SAN FRANCISCO — Ophthalmic innovations are steadily moving forward, but not quite at the rate of other specialties, Emmett T. Cunningham, Jr., MD, PhD, MPH, explained during the Ophthalmology Innovation Summit preceding the American Academy of Ophthalmology annual meeting.

SAN FRANCISCO — At the Ophthalmology Innovation Summit preceding the American Academy of Ophthalmology annual meeting, Vincent Anido, chairman and CEO of Aerie Pharmaceuticals, gives an update on the company’s products, including Rhopressa and Rocklatan.

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended marketing authorization approval for Rhokiinsa for the reduction of IOP in primary open-angle glaucoma or ocular hypertension, Aerie Pharmaceuticals announced in a press release.